Notice Type
Departmental
Notice Title

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Invirase
Active Ingredient: Saquinavir mesylate 228.7mg equivalent to 200mg Saquinavir free base
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche AG, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Note: This consent is valid for 2 years from 6 June 2002.
Dated this 22nd day of March 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).